The bio-analytical firm’s coronavirus portfolio will be made available on the IATA Travel Pass, with trials beginning over the next few weeks
The International Air Transport Association (IATA) has announced an agreement with Eurofins, which aims to incorporate the firm’s global COVID-19 testing network into the IATA Travel Pass.
The leaders in bio-analytical testing will also make its coronavirus portfolio – which includes test types and hundreds of international sampling stations – available through the app.
Secure results will be provided to customers using the platform. This information can then be shared with the authorities and airlines to streamline travel.
“Verified testing is the immediate solution to give governments the confidence to open their borders to travellers,” said Willie Walsh, IATA’s newly appointed director general. “IATA Travel Pass aims to make it as simple as possible for travellers to locate certified laboratories and securely receive the test results that governments require.
“Our partnership with Eurofins is another mark of quality for IATA Travel Pass which is being built to the highest data security and privacy standards. Adding the extensive Eurofins network to the initiative will help travellers more conveniently adjust their travel preparations to meet the COVID-19 requirements.”
Gilles Martin, Eurofins’ chairman of the board and CEO, reiterates that fast and secure testing is a “critical element in the fight against the pandemic” which will enable the return to normalised travel.
Trials of the travel pass with the incorporation of the Eurofins network are expected to commence over the next few weeks.
According to IATA, its new travel pass provides the infrastructure needed to manage, share and verify test data.
